Literature DB >> 16217659

Incidence, causes and prognosis of hypotension related to meprobamate poisoning.

Cyril Charron1, Armand Mekontso-Dessap, Karim Chergui, Anne Rabiller, François Jardin, Antoine Vieillard-Baron.   

Abstract

OBJECTIVE: Meprobamate self-poisoning has been reported as potentially inducing hypotension. We examined the incidence and causes of hypotension induced by this poisoning and its prognosis. DESIGN AND
SETTING: Retrospective observational study conducted in a medical ICU between June 1997 and October 2003. Seventy-four patients admitted for meprobamate poisoning and needing mechanical ventilation were included. Demographic, clinical, and laboratory data were compared between patients with and without hypotension. All echocardiograms recorded in patients with hypotension were reviewed, and left ventricular (LV) and right ventricular (RV) functions were assessed.
RESULTS: Twenty-nine (40%) patients exhibited hypotension without any significant difference in age, gender, cardiac history, or meprobamate concentration in blood when compared to patients without hypotension. Base excess was significantly lower in patients with hypotension. Echocardiography demonstrated a hypokinetic state, associating decreased LV ejection fraction (45+/-15%) and cardiac index (2+/-0.7 l min(-1) m(-2)), and increased inferior vena cava diameter. Most patients with hypotension received inotropic drugs by infusion, and were ventilated for significantly longer.
CONCLUSIONS: Meprobamate self-poisoning induces hypotension, notably related to cardiac failure, in about 40% of cases. This has important therapeutic consequences, as frequent inotropic drug infusion. The mechanisms of cardiac toxicity remain largely unknown, and no predictive factor could be isolated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16217659     DOI: 10.1007/s00134-005-2816-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  15 in total

Review 1.  Echo-Doppler demonstration of acute cor pulmonale at the bedside in the medical intensive care unit.

Authors:  Antoine Vieillard-Baron; Sebastien Prin; Karim Chergui; Olivier Dubourg; Francois Jardin
Journal:  Am J Respir Crit Care Med       Date:  2002-11-15       Impact factor: 21.405

2.  Acute meprobamate poisoning with gastrotomy and removal of a drug-containing mass.

Authors:  H S Schwartz
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

3.  Meprobamate poisoning and pulmonary edema.

Authors:  J A Axelson; J F Hagaman
Journal:  N Engl J Med       Date:  1977-06-23       Impact factor: 91.245

4.  Fatal meprobamate self-poisoning.

Authors:  P Kintz; A Tracqui; P Mangin; A A Lugnier
Journal:  Am J Forensic Med Pathol       Date:  1988-06       Impact factor: 0.921

Review 5.  Right heart catheterization at bedside: a critical view.

Authors:  F Jardin; J P Bourdarias
Journal:  Intensive Care Med       Date:  1995-04       Impact factor: 17.440

Review 6.  The management of acute poisoning.

Authors:  G G Collee; G C Hanson
Journal:  Br J Anaesth       Date:  1993-05       Impact factor: 9.166

7.  [Meprobamate poisoning with cardiac insufficiency. Treatment with dobutamine].

Authors:  J Longchal; A Tenaillon; P Trunet; J Labrousse; J Lissac
Journal:  Nouv Presse Med       Date:  1978-04-22

8.  [State of shock during acute meprobamate poisoning. 6 cases].

Authors:  C Landier; R Lanotte; A Legras; P F Dequin; D Perrotin
Journal:  Ann Fr Anesth Reanim       Date:  1994

9.  Meprobamate overdosage: a continuing problem.

Authors:  M D Allen; D J Greenblatt; B J Noel
Journal:  Clin Toxicol       Date:  1977-12       Impact factor: 4.467

10.  Meprobamate poisoning, hypotension and the Swan-Ganz catheter.

Authors:  E Eeckhout; L Huyghens; B Loef; V Maes; J Sennesael
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

View more
  1 in total

1.  Overdose of meprobamate: plasma concentration and Glasgow Coma Scale.

Authors:  Anne-Claire Buire; Fabien Vitry; Guillaume Hoizey; Denis Lamiable; Thierry Trenque
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.